Publication | Closed Access

Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period

Bile Duct DiseaseHepatologyBiliary TractLiver PhysiologyGastroenterologyPrimary Sclerosing CholangitisBiliary DisorderLiver DiseaseUrsodeoxycholic AcidPrimary Biliary CirrhosisCholangiopathiesMedicineAutoimmune Liver Disease